BIOGEN INC (BIIB)

US09062X1037 - Common Stock

159.99  -4.9 (-2.97%)

After market: 159.99 0 (0%)

Buy % Consensus

79

ChartMill assigns a Buy % Consensus number of 79% to BIIB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 267.82. This target is 67.4% above the current price.
BIIB was analyzed by 42 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about BIIB.
In the previous month the buy percentage consensus was at a similar level.
BIIB was analyzed by 42 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 159.99191.90274.89267.82359.10 - 19.94% 71.82% 67.40% 124.45%
Up and Down Grades
Date Firm Action Rating
2024-11-15 Wolfe Research Initiate Peer Perform
2024-11-15 Baird Maintains Outperform -> Outperform
2024-11-14 Citigroup Initiate Neutral
2024-11-04 JP Morgan Maintains Neutral -> Neutral
2024-10-31 TD Cowen Maintains Buy -> Buy
2024-10-31 Needham Reiterate Buy -> Buy
2024-10-31 Oppenheimer Maintains Outperform -> Outperform
2024-10-31 Barclays Maintains Equal-Weight -> Equal-Weight
2024-10-31 Morgan Stanley Downgrade Overweight -> Equal-Weight
2024-10-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-30 Needham Reiterate Buy -> Buy
2024-10-17 BMO Capital Maintains Outperform -> Outperform
2024-10-10 Raymond James Reiterate Market Perform
2024-10-04 RBC Capital Maintains Outperform -> Outperform
2024-10-03 UBS Maintains Neutral -> Neutral
2024-09-24 Needham Reiterate Buy -> Buy
2024-09-23 Wedbush Maintains Neutral -> Neutral
2024-09-19 RBC Capital Reiterate Outperform -> Outperform
2024-09-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-04 Needham Reiterate Buy -> Buy
2024-08-19 Needham Reiterate Buy -> Buy
2024-08-06 Mizuho Maintains Outperform -> Outperform
2024-08-05 Needham Maintains Buy -> Buy
2024-08-05 Truist Securities Reiterate Buy -> Buy
2024-08-02 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-08-02 RBC Capital Maintains Outperform -> Outperform
2024-08-02 Barclays Maintains Equal-Weight -> Equal-Weight
2024-08-02 Wedbush Maintains Neutral -> Neutral
2024-08-02 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-08-01 Needham Reiterate Buy -> Buy